MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, released a core quantum machine learning technology oriented toward sequential learning tasks—the ...
2026 non-GAAP operating expenses guidance -- $18.0 million to $18.5 million for Q1, with $1.7 million dedicated to IP ...
Ambiq Micro, Inc. (NYSE:AMBQ) Q4 2025 Earnings Call Transcript March 5, 2026 Ambiq Micro, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.39. Operator: Good morning, ...
Our Wabi Sabi Life on MSN
5 albums that are best heard from start to finish
There's a specific kind of listening pleasure that only happens when an album pulls you in from the first second and refuses to let go until the final note fades. In a world where the focus has ...
Q4 2025 Earnings Call March 5, 2026 8:30 AM ESTCompany ParticipantsCharlene Wan - Vice President of Corporate Marketing ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results